news

한어Русский языкEnglishFrançaisIndonesianSanskrit日本語DeutschPortuguêsΕλληνικάespañolItalianoSuomalainenLatina

Beijing News Shell Finance (Reporter Li Yunqi) On August 10, the third press conference of the "2024 World Life Science Conference" co-organized by Hainan University and the China Association for Science and Technology Life Science Society Consortium was held in Beijing. At the press conference, Yang Weicai, an academician of the Chinese Academy of Sciences and chairman of the China Association for Science and Technology Life Science Society Consortium, told the Beijing News Shell Finance reporter that the biopharmaceutical industry is a relatively long-term investment, and in the transformation of achievements in the field of life sciences, more "middlemen" are needed to bring scientists and entrepreneurs together.

It is reported that the 2024 World Life Sciences Congress, with the theme of "One World, Shared Health", will be held in Boao, Hainan from October 19th to 21st. Based on the exploration of new technologies in the field of life sciences, this conference has added a "Scientific Achievements Display" section. It is expected that more than 60 Chinese and foreign academicians will attend the conference.

Yang Weicai said that the lack of a bridge of communication between entrepreneurs and scientists, and between scientific research results and the market is a real problem in society. Entrepreneurs have always been unable to specialize in finding scientific research projects, resulting in uneven transformation effects of many products on the market; scientists focus on research in the laboratory, and good products and scientific research results cannot be transformed due to lack of financial support.

When talking about how the participation of leading domestic investment companies in the World Congress will drive the transformation of life science industry achievements, Yang Weicai said that this World Life Sciences Congress is to provide a bridge of communication for entrepreneurs, investors, scientists and scientific research results. The latest scientific and technological achievements will be displayed in the Achievement Exhibition Hall. Entrepreneurs and investors can fully understand the specific characteristics of the project through the Achievement Exhibition Hall and provide financial support for the transformation of scientific research results in combination with the market.

Yang Weicai told the Beijing News Shell Finance reporter that the development of the industry has its own rules. "The biopharmaceutical industry is a relatively long-term investment. It tests investors and how financial investment considers this issue. The development of a drug takes ten or twenty years. When will financial investment be integrated into the industrial chain? This is a question worth exploring."

Edit Linzi

Proofread by Lucy